|Mr. Xiang Jun Wu||Gen. Mang. and Director||N/A||N/A||1975|
|Dr. Feng Xiang Dai||CFO & Deputy GM||N/A||N/A||1965|
|Mr. Xiu Qiang Gao||Supply Center Director||N/A||N/A||1966|
|Ms. Rui Wu||Deputy GM, Sec. of the Board & Non-Independent Director||N/A||N/A||1980|
|Mr. Shao Hua Zhao||Deputy Gen. Mang.||N/A||N/A||1966|
|Ms. Yue Zhi Han||Production Management Committee Director and Deputy Gen. Mang.||N/A||N/A||1966|
|Ms. Qiu Lian Zhang||Deputy GM & Non-Independent Director||N/A||N/A||1970|
|Mr. Wei Dong Xu||Director of HR and Director||N/A||N/A||1968|
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceuticals primarily in China. It operates through three segments: Modern Chinese Medicine, Chemical Pharmaceutical, and Health Industry. The company offers drugs for cardiac and cerebral blood disease, influenza and respiratory disease, tumor, and diabetes mellitus. It sells its products through physical display, online product distribution, and join distribution parallels. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
Shijiazhuang Yiling Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.